Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from GMO Pepabo, Inc. ( (JP:3633) ).
GMO Pepabo reported consolidated net sales of ¥2.61 billion for the three months ended March 31, 2026, down 4.8% year on year, with operating profit falling 23.8% to ¥255 million and profit attributable to owners of parent declining 20.5% to ¥188 million. Basic earnings per share slipped to ¥36.52, while total assets decreased to ¥10.67 billion and the equity ratio weakened to 22.8%, signaling some pressure on profitability and financial position.
The company plans to maintain a no-dividend policy for the interim periods of fiscal 2026 and forecasts a full-year dividend of ¥93 per share, lower than the previous year’s ¥111, indicating a more conservative shareholder return stance. For the full year ending December 31, 2026, GMO Pepabo projects marginal net sales growth of 0.4% to ¥11.0 billion but expects profit declines, with ordinary profit seen down 14.6% and net profit down 16.3%, pointing to a challenging operating environment despite modest top-line expansion.
More about GMO Pepabo, Inc.
GMO Pepabo, Inc., listed on the Tokyo Stock Exchange, operates in the internet services sector, offering web-related solutions and platforms with a focus on digital businesses. The company generates consolidated net sales in the low billions of yen range and maintains a capital structure with an equity ratio in the low-20% range, reflecting a moderately leveraged balance sheet.
Average Trading Volume: 8,314
Technical Sentiment Signal: Buy
Current Market Cap: Yen9.94B
See more insights into 3633 stock on TipRanks’ Stock Analysis page.